Dealing with breast cancer is challenging at the best of times, but in this time of uncertainty and when our health care system is having to quickly adapt to the impact of COVID-19, cancer patients are facing increased challenges and changes to treatment schedules and doctors’ appointments. This can bring additional anxiety and questions around how these changes will impact the success of treatments.
We talked a lot on this blog last year about biosimilars; what they are and why it’s important to know about them. With the entry of biosimilars in the breast cancer treatment landscape due later this year, there are still questions and discussions about how it will affect current and future breast cancer patients. To help understand these questions and perspectives, we decided it was important to bring together those people who are impacted the most: patients and physicians.
Biosimilar therapies have already been in use in Canada for a few years, mostly in the chronic disease and supportive care settings. But soon they will be used for treating cancer as well. There isn’t a lot of information about these new oncology biosimilars and it’s important that breast cancer patients are aware of how their treatment plans may be impacted by these new therapies. We explore some of the emerging biosimilar therapies that will be used to treat cancer patients soon.
It’s good to set challenging goals.
I ran my first marathon the year I turned 50, and completed another two years later. I loved establishing training goals that would force me to push myself physically, and feeling healthy and strong as the result of running regularly. In November 2015, I decided on a new goal: to run another marathon in the fall of 2016, and complete it with a time fast enough to qualify for the Boston Marathon.
Cancer related fatigue is so much more than just feeling tired from a long, hard day. Your cancer treatment can cause you to experience what feels like full body exhaustion. You’re so exhausted that you can’t get out of bed and no amount of rest will give you back your energy.
February 4th marks World Cancer Day, a global event that takes place every year uniting people around the world who are concerned about the fight against cancer. Currently, 8.8 million people die from cancer globally every year and breast cancer is the most commonly diagnosed cancer in women.
Febrile neutropenia, or FN, is a common and potentially serious side effect of chemotherapy treatment.